Fiduciary Trust’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.51M Sell
202,536
-800
-0.4% -$13.8K 0.04% 205
2025
Q1
$4.45M Sell
203,336
-26,465
-12% -$579K 0.06% 182
2024
Q4
$7.33M Sell
229,801
-6,265
-3% -$200K 0.1% 128
2024
Q3
$6.81M Sell
236,066
-4,220
-2% -$122K 0.1% 142
2024
Q2
$9.22M Sell
240,286
-700
-0.3% -$26.9K 0.14% 102
2024
Q1
$14.2M Sell
240,986
-1,621
-0.7% -$95.3K 0.22% 74
2023
Q4
$14.5M Sell
242,607
-22,600
-9% -$1.35M 0.24% 69
2023
Q3
$10.1M Sell
265,207
-8,709
-3% -$331K 0.18% 90
2023
Q2
$25M Sell
273,916
-268,375
-49% -$24.4M 0.44% 46
2023
Q1
$35.8M Sell
542,291
-9,900
-2% -$653K 0.66% 29
2022
Q4
$28.6M Sell
552,191
-8,800
-2% -$455K 0.56% 39
2022
Q3
$38.3M Sell
560,991
-3,835
-0.7% -$262K 0.83% 20
2022
Q2
$25.5M Hold
564,826
0.54% 39
2022
Q1
$28.7M Sell
564,826
-15
-0% -$762 0.51% 40
2021
Q4
$26.7M Sell
564,841
-35
-0% -$1.66K 0.44% 45
2021
Q3
$18.6M Buy
564,876
+926
+0.2% +$30.5K 0.33% 57
2021
Q2
$35.6M Sell
563,950
-1,500
-0.3% -$94.8K 0.69% 26
2021
Q1
$24.3M Sell
565,450
-7,621
-1% -$327K 0.49% 43
2020
Q4
$32.8M Buy
573,071
+2,480
+0.4% +$142K 0.68% 28
2020
Q3
$17.2M Sell
570,591
-22,000
-4% -$664K 0.41% 54
2020
Q2
$19.4M Buy
592,591
+879
+0.1% +$28.7K 0.48% 45
2020
Q1
$15.9M Buy
591,712
+3,174
+0.5% +$85K 0.46% 51
2019
Q4
$18M Sell
588,538
-117,385
-17% -$3.59M 0.42% 56
2019
Q3
$17M Buy
705,923
+1,675
+0.2% +$40.3K 0.43% 55
2019
Q2
$17.8M Sell
704,248
-1,300
-0.2% -$32.9K 0.47% 48
2019
Q1
$13.8M Hold
705,548
0.37% 63
2018
Q4
$9.31M Buy
+705,548
New +$9.31M 0.29% 82